ITGB1 and neoplasm: Our findings elucidate a novel mechanism whereby Tregs enhance pathogenicity via CD29: enhanced Treg‐CD29 interactions in MASLD conditions promote tumour cell adhesion and migration, acting as potential drivers of the transition from MASH to HCC.